Literature DB >> 34218935

Male genital lichen planus: A retrospective study of 89 cases.

J Amsellem1, C Skayem2, T-A Duong3, M Bagot4, S Fouéré5, J-N Dauendorffer6.   

Abstract

BACKGROUND: Unlike other types of lichen planus (LP), there are no series concerning male genital LP.
OBJECTIVE: To describe the clinical characteristics, diagnosis, and response to treatment of male genital LP. PATIENTS AND METHODS: A retrospective study of male patients with genital LP consulting a dermatologist specialized in anogenital diseases between January 2010 and 2019. Demographic data, history, functional signs, clinical characteristics, pathology, complications, and treatment efficacy were collected.
RESULTS: Eighty-nine patients were included at four centers. The median age was 51 years. Most patients were uncircumcised and asymptomatic. In 88.8% of cases, only the genital mucosa was involved. Erythema (71%), papules (21.3%), lacy network (15.7%), atrophic lesions (15.7%), erosions (14.6%), and post-inflammatory hyperpigmentation (2.2%) were less frequently observed. Biopsy results confirmed LP in 61.3% of cases but could not rule out other inflammatory genital dermatoses in other cases. Anatomic complications were observed in 30.3% of patients. Topical corticosteroids (TCS) induced remission in most cases. Tacrolimus efficacy was comparable to that of TCS.
CONCLUSION: Male genital LP is a rare inflammatory disorder chiefly affecting uncircumcised men. It is found predominantly on the mucosal component of the penis and presents as non-erosive inflammatory balanitis in most cases, with frequent partial or complete remission on treatment with TCS.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Genital; Lichen planus; Male

Mesh:

Substances:

Year:  2021        PMID: 34218935     DOI: 10.1016/j.annder.2021.04.007

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  1 in total

1.  Lichen Planus Activity and Damage Index (LiPADI)-Creation of the Questionnaire.

Authors:  Katarzyna Stępień; Ewa Żabska; Mansur Rahnama-Hezavah; Adam Reich
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.